Le Lézard
Classified in: Health, Science and technology
Subject: SVY

Microbial Identification Market to Garner US$ 1.4 Bn by 2022 - Future Market Insights

VALLEY COTTAGE, New York, October 5, 2017 /PRNewswire/ --

FMI has recently published an exclusive forecast report on the global market for microbial identification. In the foreseeable future, improvements in techniques adopted by microbiologists for identifying pathogens and examining microbial cultures will factor developments in microbial identification systems. From healthcare to food & beverage, the vital use of microbial identification in applied research projects will continue to boost the growth of the global microbial identification market. By 2022-end, microbial identification systems are pegged to become a global market worth US$ 1.4 billion. During the forecast period, 2017-2022, the global market for microbial identification will be registering a robust growth at 6% CAGR. The report has analysed a slew of factors influencing the dynamics of microbial identification markets across several regions.

     (Logo: http://photos.prnewswire.com/prnh/20161020/430874LOGO )

Global Market Research Report Overview on Microbial Identification @ https://www.futuremarketinsights.com/reports/microbial-identification-market

North America to register steadfast adoption of microbial identification 

A key discernment from the regional analysis delivered in the report exhibits the dominance of North America in the global microbial identification market. Considering how healthcare marketplaces in the US and Canada are robust, compared to other developed markets, and taking into account the rising contribution of North American academic institutes in developing research studies of medical microbiology, the adoption of microbial identification systems will be widespread in this region. Towards the end of forecast period, North America's microbial identification market will be worth around half a billion dollars, soaring robustly at a CAGR of 6.4%. Europe and Asia-Pacific excluding Japan (APEJ) will also be observed as lucrative markets for expansion of microbial identification.

Key Findings from the Report 

In 2017, over two-fifth of revenues anticipated to be procured in the global microbial identification market will be accounted by sales of bacterial identification systems

Towards the end of forecast period, global sales of microbial remuneration systems will procure an estimated US$ 310 million in revenues

View Report Table of Contents, Figures, and Tables @ https://www.futuremarketinsights.com/reports/microbial-identification-market/toc

Throughout the forecast period, bacterial resistance identification systems will represent the fastest-selling product in the overall microbial identification market

Pharmaceuticals and biotechnology industry will remain the largest end-user of microbial identification by 2022

The end-use of microbial identification systems in water and environment sector will remain steady in 2017 and the following years

Between 2017 and 2022, the end-use of microbial identification across independent research laboratories in the world is anticipated to create an incremental opportunity of more than US$ 50 million

In 2017 and beyond, the use of microbial identification methods in blood banks will be subpar

Diagnostics remains to be a key application for microbial identification, revenues from which are anticipated to register above-average growth

A sample of this report is available upon request @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5077

While detection of harmful microbes is viewed as a necessary measure for bolstering quality control in production of food items and drinks, the application of microbial identification in food & beverage testing will register a moderate CAGR in terms of revenues over the forecast period

On the basis of technologies, phenotypic microbial identification methods are anticipated to remain predominant in terms of adoption, albeit, genotypic technologies will register a marginally high CAGR during the assessment period

The report has further profiled companies that will be actively manufacturing microbial identification systems in the global market. Key players in the global microbial identification market include, Bruker Corporation, Danaher Corporation, Thermo Fisher Scientific, Inc., Shimadzu Corporation, Siemens Healthineers, QIAGEN N.V., Merck & Co Inc., bioMerieux S.A., Becton, Dickinson and Company, and Biolog, Inc. Many of these companies are expected to focus on developing microbial identification systems that befit the advancements in the field of medical microbiology. Specific requirements of microbiologist working in leading microbial identification projects will also influence the manufacturing techniques exercised by these companies.  

Buy Microbial Identification Market Report

About Us  

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends.

Contact Us
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
T (UK): +44(0)20-7692-8790
Sales: sales@futuremarketinsights.com


These press releases may also interest you

at 12:30
Health Care Service Corporation (HCSC), which operates Blue Cross and Blue Shield® plans in Illinois, Montana, New Mexico, Oklahoma and Texas, announced the completion of its 100th playspace project with KaBOOM!®, a national nonprofit dedicated to...

at 12:29
Watercrest Senior Living Group proudly welcomes Monée Mueller as Community Relations Director of Market Street Memory Care Residence in Tampa, Florida. The 64-unit, state-of-the-art senior living community offers exceptional amenities, multi-sensory...

at 12:00
Deni Carise, Ph.D., a National Institute on Drug Abuse (NIDA) recognized addiction expert, will be educating over 100 Aetna Commercial Brokers and Plan Sponsor Employers on how communities can stem the tide of the opioid epidemic. The event will be...

at 11:45
The "Liquid Biopsy Global Market - Forecast to 2024" report has been added to ResearchAndMarkets.com's offering. According to analysis, the liquid biopsy market is projected to reach $8,730.4 million by 2024. The market is segmented based on the...

at 11:45
March of Dimes, the preeminent non-profit organization leading the fight for the health of all moms and babies, today launched a new awareness campaign focused on highlighting the urgent health crisis moms and babies in the U.S. face. The campaign,...

at 11:32
Centene Corporation today issued a reminder that it will release its 2018 first quarter financial results at approximately 6 a.m. (Eastern Time) on Tuesday, April 24, 2018, and host a conference call afterwards at approximately 8:30 a.m. (Eastern...

News published on 5 october 2017 at 09:30 and distributed by: